Table 14.2

Recipient Recurrence of Pretransplant Malignancies, 1997 to 2006

by Transplant Type

Organ Type Year of Transplant
1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
Total Total Recipients 20,322 21,542 22,045 23,266 24,244 24,919 25,484 27,048 28,109 28,931
# With Pre-Tx Malignancy (1) 479 567 744 873 1,002 1,205 1,211 1,278 1,403 1,546
# With Recurrence of Pre-Tx Malignancy (2) 22 21 57 52 54 67 54 35 36 21
% With Recurrence of Pre-Tx Malignancy (3) 4.6% 3.7% 7.7% 6.0% 5.4% 5.6% 4.5% 2.7% 2.6% 1.4%
# With Recurrence, but no Pre-Tx Malignancy (4) 38 60 32 34 60 61 71 80 67 24
Kidney Total Recipients 11,701 12,452 12,760 13,612 14,266 14,779 15,137 16,004 16,481 17,093
# With Pre-Tx Malignancy (1) 232 262 329 347 423 459 465 504 659 737
# With Recurrence of Pre-Tx Malignancy (2) 8 3 13 11 6 8 8 7 6 5
% With Recurrence of Pre-Tx Malignancy (3) 3.4% 1.1% 4.0% 3.2% 1.4% 1.7% 1.7% 1.4% 0.9% 0.7%
# With Recurrence, but no Pre-Tx Malignancy (4) 7 9 9 11 10 9 13 4 7 1
Pancreas Transplant Alone Total Recipients 79 88 139 134 167 180 158 182 198 169
# With Pre-Tx Malignancy (1) 1 2 3 5 7 5 4 5 7 3
# With Recurrence of Pre-Tx Malignancy (2) - - - 1 1 - - - - -
% With Recurrence of Pre-Tx Malignancy (3) - - - 20.0% 14.3% - - - - -
# With Recurrence, but no Pre-Tx Malignancy (4) - - - - - - 1 - 1 -
Pancreas After Kidney Total Recipients 130 156 220 304 305 375 344 420 343 293
# With Pre-Tx Malignancy (1) 2 1 3 8 8 8 5 10 7 9
# With Recurrence of Pre-Tx Malignancy (2) - - - - - - - - - -
% With Recurrence of Pre-Tx Malignancy (3) - - - - - - - - - -
# With Recurrence, but no Pre-Tx Malignancy (4) - - - - - - - - - -
Kidney-Pancreas Total Recipients 853 972 941 915 891 905 871 881 903 924
# With Pre-Tx Malignancy (1) 4 9 11 8 13 9 8 8 13 18
# With Recurrence of Pre-Tx Malignancy (2) - - - - - - - - - -
% With Recurrence of Pre-Tx Malignancy (3) - - - - - - - - - -
# With Recurrence, but no Pre-Tx Malignancy (4) - - - - 1 1 1 - - -
Liver Total Recipients 4,188 4,516 4,751 4,995 5,191 5,331 5,673 6,169 6,441 6,649
# With Pre-Tx Malignancy (1) 148 192 300 402 413 612 607 609 553 583
# With Recurrence of Pre-Tx Malignancy (2) 12 18 38 35 43 58 43 27 28 16
% With Recurrence of Pre-Tx Malignancy (3) 8.1% 9.4% 12.7% 8.7% 10.4% 9.5% 7.1% 4.4% 5.1% 2.7%
# With Recurrence, but no Pre-Tx Malignancy (4) 28 43 21 20 46 47 55 73 58 23
Intestine Total Recipients 68 70 73 82 112 107 116 152 176 174
# With Pre-Tx Malignancy (1) 3 3 1 4 4 4 6 9 2 5
# With Recurrence of Pre-Tx Malignancy (2) - - - 1 1 - 1 - - -
% With Recurrence of Pre-Tx Malignancy (3) - - - 25.0% 25.0% - 16.7% - - -
# With Recurrence, but no Pre-Tx Malignancy (4) - - - - - - 1 - - -
Heart Total Recipients 2,293 2,348 2,188 2,199 2,202 2,155 2,057 2,015 2,125 2,192
# With Pre-Tx Malignancy (1) 72 73 75 70 98 72 78 95 101 106
# With Recurrence of Pre-Tx Malignancy (2) 2 - 4 1 2 - 2 1 1 -
% With Recurrence of Pre-Tx Malignancy (3) 2.8% - 5.3% 1.4% 2.0% - 2.6% 1.1% 1.0% -
# With Recurrence, but no Pre-Tx Malignancy (4) 2 5 1 2 1 3 - 1 - -
Lung Total Recipients 948 893 922 977 1,083 1,054 1,099 1,185 1,407 1,406
# With Pre-Tx Malignancy (1) 17 25 22 28 34 35 35 37 60 85
# With Recurrence of Pre-Tx Malignancy (2) - - 2 3 1 1 - - 1 -
% With Recurrence of Pre-Tx Malignancy (3) - - 9.1% 10.7% 2.9% 2.9% - - 1.7% -
# With Recurrence, but no Pre-Tx Malignancy (4) 1 3 1 1 2 1 - 2 1 -
Heart-Lung Total Recipients 62 47 51 48 27 33 29 40 35 31
# With Pre-Tx Malignancy (1) - - - 1 2 1 3 1 1 -
# With Recurrence of Pre-Tx Malignancy (2) - - - - - - - - - -
% With Recurrence of Pre-Tx Malignancy (3) - - - - - - - - - -
# With Recurrence, but no Pre-Tx Malignancy (4) - - - - - - - - - -


Source: OPTN/SRTR Data as of May 1, 2007.

(-) = None in category.

Includes both deceased and living donor transplants.

(1) Pre-Tx malignancy reported on the TCR or TRR Form.

(2) Recurrence reported on the Transplant Recipient Follow-up Form.

(3) Percent recurrence is calculated based on total with reported pre-tx malignancy.

(4) Recurrence reported on the follow-up form, but no pre-tx malignancy reported, so these are not included in recurrence rates.

Recipient malignancy statistics are based on voluntary reporting to the OPTN